{"version":"1.0","provider_name":"Lutathera EU HCP","provider_url":"https:\/\/euhcp.lutathera.com","title":"For HCPs - Lutathera EU HCP","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\"><a href=\"https:\/\/euhcp.lutathera.com\/\">For HCPs<\/a><\/blockquote>\n<script type='text\/javascript'>\n<!--\/\/--><![CDATA[\/\/><!--\n\t\t\/*! This file is auto-generated *\/\n\t\t!function(c,d){\"use strict\";var e=!1,n=!1;if(d.querySelector)if(c.addEventListener)e=!0;if(c.wp=c.wp||{},!c.wp.receiveEmbedMessage)if(c.wp.receiveEmbedMessage=function(e){var t=e.data;if(t)if(t.secret||t.message||t.value)if(!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var r,a,i,s=d.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),n=d.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),o=0;o<n.length;o++)n[o].style.display=\"none\";for(o=0;o<s.length;o++)if(r=s[o],e.source===r.contentWindow){if(r.removeAttribute(\"style\"),\"height\"===t.message){if(1e3<(i=parseInt(t.value,10)))i=1e3;else if(~~i<200)i=200;r.height=i}if(\"link\"===t.message)if(a=d.createElement(\"a\"),i=d.createElement(\"a\"),a.href=r.getAttribute(\"src\"),i.href=t.value,i.host===a.host)if(d.activeElement===r)c.top.location.href=t.value}}},e)c.addEventListener(\"message\",c.wp.receiveEmbedMessage,!1),d.addEventListener(\"DOMContentLoaded\",t,!1),c.addEventListener(\"load\",t,!1);function t(){if(!n){n=!0;for(var e,t,r=-1!==navigator.appVersion.indexOf(\"MSIE 10\"),a=!!navigator.userAgent.match(\/Trident.*rv:11\\.\/),i=d.querySelectorAll(\"iframe.wp-embedded-content\"),s=0;s<i.length;s++){if(!(e=i[s]).getAttribute(\"data-secret\"))t=Math.random().toString(36).substr(2,10),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t);if(r||a)(t=e.cloneNode(!0)).removeAttribute(\"security\"),e.parentNode.replaceChild(t,e)}}}}(window,document);\n\/\/--><!]]>\n<\/script><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/euhcp.lutathera.com\/embed\/\" width=\"600\" height=\"338\" title=\"&#8220;For HCPs&#8221; &#8212; Lutathera EU HCP\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe>","description":"[vc_row el_class=&#8221;hero hero&#8211;green-line&#8221;][vc_column el_class=&#8221;hero__wrap hero__wrap&#8211;right&#8221;][vc_column_text el_class=&#8221;hero__content&#8221;] LUTATHERA\u00ae Lutetium (177Lu) oxodotreotide POWER AGAINST PROGRESSION Indication: LUTATHERA\u00ae is indicated for the treatment of unresectable or metastatic, progressive, well differentiated (G1 and G2), somatostatin receptor positive gastroenteropancreatic neuroendocrine tumours (GEPNETs) in adults.[\/vc_column_text][vc_btn title=&#8221;Dosing and Administration&#8221; el_class=&#8221;button button&#8211;align-left button&#8211;green&#8221; link=&#8221;url:%2Fabout-lutathera%2F%23dosing|||&#8221;][\/vc_column][\/vc_row][vc_row el_class=&#8221;three-grid&#8221;][vc_column width=&#8221;1\/3&#8243; el_class=&#8221;three-grid__col promo-block&#8221;][vc_column_text el_class=&#8221;promo-block__header&#8221;]EFFICACY[\/vc_column_text][vc_column_text el_class=&#8221;promo-block__text&#8221;]82% risk reduction of &hellip; Continue reading \"\""}